

"Award-winning hemodialysis system delivering all dialysis modalities in any care setting"
Quanta Dialysis Technologies develops the Quanta Dialysis System, the first FDA-cleared device offering every hemodialysis modality in one bagless platform. The system delivers IHD, SLED, and CRRT for acute care, plus home hemodialysis, streamlining kidney replacement therapy from ICU to home. Designed for clinical flexibility, ease of training, and minimal maintenance, it addresses staffing challenges and treatment delays. Hospitals, dialysis centres, and patients benefit from a single platform eliminating multiple devices. Quanta's on-demand dialysate technology, which earned the Royal Academy of Engineering MacRobert Award, expands access to quality kidney care whilst reducing complexity across acute, in-centre, and home settings.


240
Team Members
2008
Founded
Medical Devices
Sector
Hybrid
Work Environment
A world where every kidney patient accesses the dialysis care they need in the setting they prefer, without barriers of location, complexity, or cost.
Quanta Dialysis Technologies expands access to quality kidney care by delivering clinically flexible, intuitive hemodialysis technology across every care setting.